Trial Details
RECRUITINGBasic Information
| Clinical ID | c1067 |
|---|---|
| Identifier | NCT04133194 |
| Trial Title | Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mesalazine|DRUG: Mesalazine |
Participant Information
| Sponsor | Flemming Bendtsen |
|---|---|
| City | Hvidovre |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-11-28 |
|---|---|
| Primary Completion Date | 2024-12-31 |
| Completion Date | 2025-03-01 |